Neogen Eyes Up To Low-Double-Digit Revenue Growth by Fiscal 2031
MT Newswires Live
Yesterday
Neogen (NEOG) is targeting high-single-digit to low-double-digit total revenue growth and a 30% adjusted EBITDA margin by fiscal 2031, the company said late Wednesday.
Neogen plans to increase R&D investment by about 50% in fiscal 2027 and target R&D investment of about 5% of revenue by fiscal 2031, with new products expected to add $100 million in revenue by then.
The company is on track to make saleable Petrifilm product and start the manufacturing transition of the product to its site in Lansing, Michigan, effective November, it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.